Market Cap 1.60B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 2,959,000
Avg Vol 7,310,530
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 13%
Beta 1.18
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Money_maker777
Money_maker777 Jun. 14 at 11:49 PM
$ABCL “nsults aren’t analysis. If you have data, present it. If not, the name‑calling doesn’t change the fundamentals.
1 · Reply
Money_maker777
Money_maker777 Jun. 14 at 11:47 PM
$ABCL Nobody is paying people to talk about a $5 biotech. If you think every green candle is a pump, you’re trading emotions, not fundamentals
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 11:47 PM
$ABCL Biotech drawdowns from 2021 are macro‑driven, not ABCL‑specific. Phase 1 is a safety readout, not an efficacy catalyst, so price action there doesn’t predict Phase 2. If you have actual scientific concerns about the target or mechanism, list them otherwise calling it junk doesn’t make it junk.
0 · Reply
tradersunion353
tradersunion353 Jun. 14 at 10:27 PM
$ABCL why would any stock has such a disastrous performance for last 5 years lost 85% share value the only blockbuster news was phase1 data where it dropped 30% phase 2 i highly doubt it will be good - these are paid punpers on x and here who are pumping this ugly pos
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 9:50 PM
$ABCL Phase 2 outcomes depend on biology, not your feelings. If you have actual scientific concerns, list them. If not, you’re just predicting weather.
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 9:47 PM
$ABCL Phase 1 isn’t designed to move stock price it’s designed to show safety. If you’re trading biotech without knowing that, you’re not analyzing, you’re guessing.
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 9:46 PM
$ABCL Calling ABCL ‘overhyped’ while it has 100+ partnered programs is wild. That’s not hype that’s a pipeline.
0 · Reply
ChipDistribution7
ChipDistribution7 Jun. 14 at 6:55 PM
$ABCL No change in plan. Closed above 200WMA, but not a buy trigger yet Ideally want a retest of 50DMA before entry Wave 5 target: +165% Still waiting for a cleaner setup.
0 · Reply
tradersunion353
tradersunion353 Jun. 14 at 12:45 PM
$ABCL looking at stock performance after phase1 data i am sure this junk will crash probably to $1 after phase 2 data????
0 · Reply
tradersunion353
tradersunion353 Jun. 14 at 12:39 PM
$ABCL overhyped underperforming junkie a bunch of paid clowns restleslly pumping this junkie will not help.. thats overdine
0 · Reply
Latest News on ABCL
AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 10 days ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 4 weeks ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 weeks ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 weeks ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 weeks ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 weeks ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 5 weeks ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 6 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 6 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 2 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 5 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 10 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 11 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 11 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Money_maker777
Money_maker777 Jun. 14 at 11:49 PM
$ABCL “nsults aren’t analysis. If you have data, present it. If not, the name‑calling doesn’t change the fundamentals.
1 · Reply
Money_maker777
Money_maker777 Jun. 14 at 11:47 PM
$ABCL Nobody is paying people to talk about a $5 biotech. If you think every green candle is a pump, you’re trading emotions, not fundamentals
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 11:47 PM
$ABCL Biotech drawdowns from 2021 are macro‑driven, not ABCL‑specific. Phase 1 is a safety readout, not an efficacy catalyst, so price action there doesn’t predict Phase 2. If you have actual scientific concerns about the target or mechanism, list them otherwise calling it junk doesn’t make it junk.
0 · Reply
tradersunion353
tradersunion353 Jun. 14 at 10:27 PM
$ABCL why would any stock has such a disastrous performance for last 5 years lost 85% share value the only blockbuster news was phase1 data where it dropped 30% phase 2 i highly doubt it will be good - these are paid punpers on x and here who are pumping this ugly pos
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 9:50 PM
$ABCL Phase 2 outcomes depend on biology, not your feelings. If you have actual scientific concerns, list them. If not, you’re just predicting weather.
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 9:47 PM
$ABCL Phase 1 isn’t designed to move stock price it’s designed to show safety. If you’re trading biotech without knowing that, you’re not analyzing, you’re guessing.
0 · Reply
Money_maker777
Money_maker777 Jun. 14 at 9:46 PM
$ABCL Calling ABCL ‘overhyped’ while it has 100+ partnered programs is wild. That’s not hype that’s a pipeline.
0 · Reply
ChipDistribution7
ChipDistribution7 Jun. 14 at 6:55 PM
$ABCL No change in plan. Closed above 200WMA, but not a buy trigger yet Ideally want a retest of 50DMA before entry Wave 5 target: +165% Still waiting for a cleaner setup.
0 · Reply
tradersunion353
tradersunion353 Jun. 14 at 12:45 PM
$ABCL looking at stock performance after phase1 data i am sure this junk will crash probably to $1 after phase 2 data????
0 · Reply
tradersunion353
tradersunion353 Jun. 14 at 12:39 PM
$ABCL overhyped underperforming junkie a bunch of paid clowns restleslly pumping this junkie will not help.. thats overdine
0 · Reply
bonecrack_benny
bonecrack_benny Jun. 13 at 7:27 AM
0 · Reply
CosmicMiner
CosmicMiner Jun. 12 at 9:01 PM
$ABCL wave 5 looks fully completed at the classic 2.618 Fib extension around $6.79. Sold my entire position here. Price has dropped to the 0.382 Fib for a potential wave B bounce, but I prefer waiting for a deeper correction into the $4S to re-enter. Long term, AI integration into drug discovery makes $ABCL a winner, but waiting for it to cool off first.
0 · Reply
Money_maker777
Money_maker777 Jun. 12 at 7:59 PM
$ABCL $ABCL A 30% move after Phase 1 says nothing about Phase 2 , early‑stage biotechs routinely swing on sentiment, not science. Phase 1 only tests safety. Meanwhile, the company just added Dr. Sandor, a guy behind multiple FDA‑approved oncology drugs. If the data was ‘almost confirmed bad,’ they wouldn’t be upgrading their clinical firepower. Shorts pushing fear while ignoring facts is predictable.
1 · Reply
tradersunion353
tradersunion353 Jun. 12 at 7:56 PM
$ABCL No stock will behave like this., almost confirmed that phase 2 data is bad? because it drooped 30% after phase 1 data... Dont believe in clowns who are married to this scam here
0 · Reply
Ckkung71
Ckkung71 Jun. 12 at 7:55 PM
$ABCL Low volume today easy fore them…..
0 · Reply
Money_maker777
Money_maker777 Jun. 12 at 7:51 PM
$ABCL Dr. Sandor joining $ABCL is the clearest sign yet they’re moving from platform → pipeline. Big things coming. 📈
0 · Reply
Money_maker777
Money_maker777 Jun. 12 at 7:39 PM
$ABCL Hedge funds and insiders are loading up, this is a $10 stock by end of year imo.
0 · Reply
tradersunion353
tradersunion353 Jun. 12 at 7:03 PM
$ABCL 500 dollar stock... cant even hold 6 dollars for a week DEMAMP.. clown is that you with another fake id?
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jun. 12 at 4:51 PM
$ABCL if each drug nets $1B a year that means in 10 years well have $500 stock if theres no dilution. I will be a multi millionaire in 10 years
0 · Reply
tradersunion353
tradersunion353 Jun. 12 at 3:45 PM
$ABCL scam badly wants to make all time record lows
1 · Reply
Biohero
Biohero Jun. 12 at 1:53 PM
$ABCL first bag loaded, lets go
1 · Reply
tradersunion353
tradersunion353 Jun. 12 at 11:21 AM
$ABCL overhyped underperforming junk ready to drop to 4.50s??? demamp and other clowns ready to add more till zero ?? 😂😂
0 · Reply